Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-01-12 to 2024-01-22
Current total value of award: $370.36
Description: 8510383400!CEFTAZIDIME FOR INJ